Testosterone supplementation and body composition: results from a meta-analysis of observational studies. (Q38848541)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

0 references

1 reference

title

Testosterone supplementation and body composition: results from a meta-analysis of observational studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

G Corona

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

V A Giagulli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

E Maseroli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

A Aversa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

M Zitzmann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

F Saad

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

E Mannucci

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

M Maggi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

publication date

30 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

3 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

967-981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27241317%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s40618-016-0480-2

3 April 2020

exact match

0 references

cites work

Management of obesity: improvement of health-care training and systems for prevention and care

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Erectile dysfunction and central obesity: an Italian perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Androgen regulation of prostate cancer: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Obesity and late-onset hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Vascular and Chronological Age in Subjects with Erectile Dysfunction: A Cross-Sectional Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Prevalence of male secondary hypogonadism in moderate to severe obesity and its relationship with insulin resistance and excess body weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Vascular and Chronological Age in Men With Erectile Dysfunction: A Longitudinal Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

How to recognize late-onset hypogonadism in men with sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Injectable testosterone undecanoate for the treatment of hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Bariatric surgery: a best practice article

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

The efficacy and safety of testosterone undecanoate (Nebido(®)) in testosterone deficiency syndrome in Korean: a multicenter prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Value of measuring muscle performance to assess changes in lean mass with testosterone and growth hormone supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Effect of testosterone replacement therapy on bone mineral density in patients with Klinefelter syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Testosterone replacement alone for testosterone deficiency syndrome improves moderate lower urinary tract symptoms: one year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Effects of testosterone treatment on body composition in males with testosterone deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Androgen Receptor Gene CAG Repeat Polymorphism Regulates the Metabolic Effects of Testosterone Replacement Therapy in Male Postsurgical Hypogonadotropic Hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Short term testosterone replacement therapy improves libido and body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Testosterone responses to standardized short-term sub-maximal and maximal endurance exercises: issues on the dynamic adaptive role of the hypothalamic-pituitary-testicular axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Effects of Testosterone Treatment in Older Men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Emerging medication for the treatment of male hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0480-2

Prevalence of late-onset hypogonadism in men with type 2 diabetes mellitus

21 January 2018

1 reference

12 December 2020

Randomized clinical trial of testosterone replacement therapy in hypogonadal men

1 reference

12 December 2020

Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.

1 reference

12 December 2020

Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements

1 reference

12 December 2020

Increase in hepatic lipase activity after testosterone substitution in men with hypogonadism of pituitary origin

1 reference

12 December 2020

Testosterone undecanoate improves erectile dysfunction in hypogonadal men with the metabolic syndrome refractory to treatment with phosphodiesterase type 5 inhibitors alone

1 reference

12 December 2020

Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism

1 reference

12 December 2020

Effect of testosterone on abdominal adipose tissue in men

1 reference

12 December 2020

Impact of a physician-supervised exercise-nutrition program with testosterone substitution in partial androgen-deficient middle-aged obese men

1 reference

12 December 2020

Testosterone replacement increases fat-free mass and muscle size in hypogonadal men.

1 reference

12 December 2020

Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients

1 reference

12 December 2020

Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males

1 reference

12 December 2020

The pharmacotherapy of male hypogonadism besides androgens

1 reference

12 December 2020

Hypogonadism and metabolic syndrome

1 reference

12 December 2020

Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins

1 reference

12 December 2020

Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism

1 reference

12 December 2020

Hypogonadism in aged hospitalized male patients: prevalence and clinical outcome

1 reference

12 December 2020

Sequence of Changes in Body Composition Induced by Testosterone and Reversal of Changes After Drug Is Stopped

1 reference

12 December 2020

Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

1 reference

12 December 2020

Trained and untrained males show reliable salivary testosterone responses to a physical stimulus, but not a psychological stimulus

1 reference

12 December 2020

Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study

1 reference

12 December 2020

Andrological characterization of the patient with diabetes mellitus

1 reference

12 December 2020

Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues

1 reference

12 December 2020